Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001842952-25-000048
Filing Date
2025-05-07
Accepted
2025-05-07 16:05:50
Documents
55
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cntx-20250331.htm   iXBRL 10-Q 553796
2 EX-31.1 cntx2025-033110xqexhibit311.htm EX-31.1 10760
3 EX-31.2 cntx2025033110-qexhibit312.htm EX-31.2 10762
4 EX-32.1 cntx2025033110-qexhibit321.htm EX-32.1 6565
  Complete submission text file 0001842952-25-000048.txt   3707429

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cntx-20250331.xsd EX-101.SCH 26990
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cntx-20250331_cal.xml EX-101.CAL 32111
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cntx-20250331_def.xml EX-101.DEF 101249
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cntx-20250331_lab.xml EX-101.LAB 432686
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cntx-20250331_pre.xml EX-101.PRE 283758
57 EXTRACTED XBRL INSTANCE DOCUMENT cntx-20250331_htm.xml XML 360646
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40654 | Film No.: 25921285
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)